TAT-BH4 and TAT-Bcl-xL peptides protect against sepsis-induced lymphocyte apoptosis in vivo

Journal of Immunology

Volumn 176, Issue 9, 2006, Pages 5471-5477

  Hotchkiss, Richard S ^a,c   McConnell, Kevin W ^a   Bullok, Kristin ^a   Davis, Christopher G ^a   Chang, Katherine C ^a   Schwulst, Steven J ^a   Dunne, Jeffrey C ^a   Dietz, Gunnar P H ^b   Bähr, Mathias ^b   McDunn, Jonathan E ^a   Karl, Irene E ^a   Wagner, Tracey H ^a   Cobb, J Perren ^a   Coopersmith, Craig M ^a   Piwnica Worms, David ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

^c Department of Anesthesiology ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; HYBRID PROTEIN; PEPTIDE; PROTEIN BCL XL; RNA; TRANSACTIVATOR PROTEIN;

ANIMAL CELL; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; ESCHERICHIA COLI; FLOW CYTOMETRY; GENE EXPRESSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LASER MICROSCOPY; LYMPHOCYTE; MICROARRAY ANALYSIS; MOUSE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTECTION; SEPSIS; SURVIVAL; WESTERN BLOTTING;

EID: 33645988546     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.176.9.5471     Document Type: Article

References (37)

1. Angus, D. C., W. T. Linde-Zwirble, J. Lidicker, G. Clermont, J. Carcillo, and M. R. Pinsky. 2001. Epidemiology of severe sepsis in the United States. Crit. Care Med. 29: 1303-1310.
2. Murphy, S. L. 1998. Deaths: final data for 1998. Natl. Vital Stat. Rep. 48: 1-105.
3. Hotchkiss, R. S., P. E. Swanson, B. D. Freeman, K. W. Tinsley, J. P. Cobb, G. M. Matuschak, T. G. Buchman, and I. E. Karl. 1999. Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit. Care Med. 27: 1230-1251.
4. + T lymphocytes in humans. J. Immunol. 166: 6952-6963.
5. Hotchkiss, R. S., K. W. Tinsley, P. E. Swanson, M. H. Grayson, D. F. Osborne, T. H. Wagner, J. P. Cobb, C. Coopersmith, and I. E. Karl. 2002. Depletion of dendritic cells, but not macrophages, in patients with sepsis. J. Immunol. 168: 2493-2500.
6. Toti, P., C. De Felice, R. Occhini, K. Schuerfeld, M. Stumpo, M. C. Epistolato, R. Vatti, and G. Buonocore. 2004. Spleen depletion in neonatal sepsis and chorioamnionitis. Am. J. Clin. Pathol. 122: 765-771.
7. Felmet, K. A., M. W. Hall, R. S. Clark, R. Jaffe, and J. A. Carcillo. 2005. Prolonged lymphopenia, lymphoid depletion, and hypoprolactinemia in children with nosocomial sepsis and multiple organ failure. J. Immunol. 174: 3765-3772.
8. Efron, P. A., K. Tinsley, D. J. Minnich, V. Monterroso, J. Wagner, P. Lainee, K. Lorre, P. E. Swanson, R. Hotchkiss, and L. L. Moldawer. 2004. Increased lymphoid tissue apoptosis in baboons with bacteremic shock. Shock 21: 566-571.
9. Hotchkiss, R. S., S. B. Osmon, K. C. Chang, T. H. Wagner, C. M. Coopersmith, and I. E. Karl. 2005. Accelerated lymphocyte death in sepsis occurs by both the death receptor and mitochondrial pathways. J. Immunol. 174: 5110-5118.
10. Hotchkiss, R. S., K. C. Chang, M. H. Grayson, K. W. Tinsley, B. S. Dunne, C. G. Davis, D. F. Osborne, and I. E. Karl. 2003. Adoptive transfer of apoptotic splenocytes worsens survival, whereas adoptive transfer of necrotic splenocytes improves survival in sepsis. Proc. Natl. Acad. Sci. USA 100: 6724-6729.
11. Hotchkiss, R. S., P. E. Swanson, C. M. Knudson, K. C. Chang, J. P. Cobb, D. F. Osborne, K. M. Zollner, T. G. Buchman, S. J. Korsmeyer, and I. E. Karl. 1999. Overexpression of Bcl-2 in transgenic mice decreases apoptosis and improves survival in sepsis. J. Immunol. 162: 4148-4156.
12. Hotchkiss, R. S., K. W. Tinsley, P. E. Swanson, K. C. Chang, J. P. Cobb, T. G. Buchman, S. J. Korsmeyer, and I. E. Karl. 1999. Prevention of lymphocyte cell death in sepsis improves survival in mice. Proc. Natl. Acad. Sci. USA 96: 14541-14546.
13. Chung, C. S., G. Y. Song, J. Lomas, H. H. Simms, I. H. Chaudry, and A. Ayala. 2003. Inhibition of Fas/Fas ligand signaling improves septic survival: differential effects on macrophage apoptotic and functional capacity. J. Leukocyte Biol. 74: 344-351.
14. Coopersmith, C., P. E. Stromberg, W. M. Dunne, C. G. Davis, D. M. Amiot 2nd, T. G. Buchman, I. E. Karl, and R. S. Hotchkiss. 2002. Inhibition of intestinal epithelial apoptosis and survival in a murine model of pneumonia-induced sepsis. J. Am. Med. Assoc. 287: 1716-1721.
15. Wesche-Soldato, D. E., C. S. Chung, J. Lomas-Neira, L. A. Doughty, S. H. Gregory, and A. Ayala. 2005. In vivo delivery of caspase 8 or Fas siRNA improves the survival of septic mice. Blood 106: 2295-2301.
16. Weaver, J. G., M. S. Rouse, J. M. Steckelberg, and A. D. Badley. 2004. Improved survival in experimental sepsis with an orally administered inhibitor of apoptosis. FASEB J. 18: 1185-1191.
17. Iwata, A., V. M. Stevenson, A. Minerd, M. Tasch, J. Tupper, E. Lagasse, I. Weissman, J. M. Harlan, and R. K. Winn. 2003. Over-expression of Bcl-2 provides protection in septic mice by a trans effect. J. Immunol. 171: 3136-3141.
18. Oberholzer, C., A. Oberholzer, F. R. Bahjat, R. M. Minter, C. L. Tannahill, A. Abouhamze, D. LaFace, B. Hutchins, M. J. Clare-Salzler, and L. L. Moldawer. 2001. Targeted adenovirus-induced expression of 1L-10 decreases thymic apoptosis and improves survival in murine sepsis. Proc. Natl. Acad. Sci. USA 98: 11503-11508.
19. Schwarze, S. R., A. Ho, A. Vocero-Akbani, and S. F. Dowdy. 1999. In vivo protein transduction: delivery of a biologically active protein into the mouse. Science 285: 1569-1572.
20. L is protective after middle cerebral artery occlusion in mice. Ann. Neurol. 52: 617-622.
21. L fusion protein containing the TAT protein transduction domain protects against ischemic brain injury and neuronal apoptosis. J. Neurosci. 22: 5423-5431.
22. L exerts anti-apoptotic activity in vivo. Oncogene 22: 8432-8440.
23. Asoh, S., I. Ohsawa, T. Mori, K. Katsura, T. Hiraide, Y. Katayama, M. Kimura, D. Ozaki, K. Yamagata, and S. Ohta. 2002. Protection against ischemic brain injury by protein therapeutics. Proc. Natl. Acad. Sci. USA 99: 17107-17112.
24. Denicourt, C., and S. F. Dowdy. 2003. Protein transduction technology offers novel therapeutic approach for brain ischemia. Trends Pharmacol. Sci. 24: 216-218.
25. L attenuates ischemia/reperfusion injury through anti-apoptotic mechanism in rat hearts. Eur. J. Cardiothorac. Surg. 27: 117-121.
26. Dietz, G. P., and M. Bahr. 2004. Delivery of bioactive molecules into the cell: the Trojan horse approach. Mol. Cell. Neurosci. 27: 85-131.
27. Dietz, G. P., E. Kilic, and M. Bahr. 2002. Inhibition of neuronal apoptosis in vitro and in vivo using TAT-mediated protein transduction. Mol. Cell. Neurosci. 21: 29-37.
28. Bullok, K. E., S. T. Gammon, S. Violini, A. M. Prantner, V. M. Villalobos, V. Sharma, and D. Piwnica-Worms. Permeation peptide conjugates for in vivo molecular imaging applications. Mol. Imaging. In press.
29. L and Bcl-2 repress a common pathway of cell death. J. Exp. Med. 182: 821-828.
30. Baker, C. C., I. H. Chaudry, H. O. Gaines, and A. E. Baue. 1983. Evaluation of factors affecting mortality rate after sepsis in a murine cecal ligation and puncture model. Surgery 94: 331-335.
31. Hotchkiss, R. S., K. C. Chang, P. E. Swanson, K. W. Tinsley, J. J. Hui, P. Klender, S. Xamhoudakis, S. Roy, C. Black, E. Grimm, et al. 2000. Caspase inhibitors improve survival in sepsis: a critical role of the lymphocyte. Nat. Immunol. 1: 496-501.
32. Gammon, S. T., V. M. Villalobos, J. L. Prior, V. Sharma, and D. Piwnica-Worms. 2003. Quantitative analysis of permeation peptide complexes labeled with Technetium-99m: chiral and sequence-specific effects on net cell uptake. Bioconjug. Chem. 14: 368-376.
33. 99mTc-tricarbonyl and fluorescein for scintigraphy and fluorescence microscopy. Bioconjug. Chem. 13: 1226-1237.
34. Bilbault, P., T. Lavaux, A. Lahlou, B. Uring-Lambert, M. P. Gaub, C. Ratomponirina, N. Meyer, P. Oudet, and F. Schneider. 2004. Transient Bcl-2 gene down-expression in circulating mononuclear cells of severe sepsis patients who died despite appropriate intensive care. Intensive Care Med. 30: 408-415.
35. Bullok, K., and D. Piwnica-Worms. 2005. Synthesis and characterization of a small, membrane-permeant, caspase-activatable far-red fluorescent peptide for imaging apoptosis. J. Med. Chem. 48: 5404-5407.
36. Su, X., J. Cheng, W. Liu, C. Liu, Z. Wang, P. Yang, T. Zhou, and J. D. Mountz. 1998. Autocrine and paracrine apoptosis are mediated by differential regulation of Fas ligand activity in two distinct Jurkat T cell populations. J. Immunol. 160: 5288-5293.
37. Wang, Y., T. Whittall, E. McGowan, J. Younson, C. Kelly, L. A. Bergmeier, M. Singh, and T. Lehner. 2005. Identification of stimulating and inhibitory epitopes within the heat shock protein 70 molecule that modulate cytokine production and maturation of dendritic cells. J. Immunol. 174: 3306-3316.